Cite
HARVARD Citation
Lachmann, H. et al. (n.d.). SAT0532 Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF-Receptor Associated Periodic Syndrome (TRAPS). Annals of the rheumatic diseases. pp. 852-853. [Online].